Johnson & Johnson suspends Covid vaccine trial as participant falls ill

0
13


WASHINGTON: Johnson & Johnson said on Monday it had temporarily halted its Covid-19 vaccine trial because one of its participants fell ill.
“We have temporarily suspended additional dosing in all of our Covid-19 vaccine candidate clinical trials, including the Phase 3 ENSEMBLE trial, due to unexplained illness in a study participant,” the company said. in a press release.
The hiatus means the online registration system has been shut down for the 60,000 patient clinical trial while the independent patient safety committee is convened.

LEAVE A REPLY

Please enter your comment!
Please enter your name here